This compound is a vitamin D analog intermediate, specifically a protected form of the calcitriol side chain with tert-butyl(dimethyl)silyl (TBDMS) ether groups at the 3- and 5-positions of the cyclohexylidene ring. Its primary significance lies in its use as a building block for the synthesis of vitamin D derivatives in pharmaceutical research and development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 128387-35-9
(R)-6-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-2-methylheptan-2-ol
research compound
(((3S,E)-5-(2-((1R,7AR,E)-7a-methyl-1-((R)-6-methylheptan-2-yl)octahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diyl)bis(oxy))bis(tert-butyldimethylsilane)
pharmaceutical intermediate
[[(1a,3b,5E,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethylsilane]
pharmaceutical intermediate
Bis-TBDMS-trans-calcipotriol
pharmaceutical intermediate
1alpha-Hydroxy VD4
pharmaceutical intermediate
Eldecalcitol Intermediate CD
pharmaceutical intermediate
3-(Difluoromethoxy)-2,4,5-trifluorobenzoic acid
pharmaceutical intermediate
4-Fluoro-3-methoxybenzaldehyde
pharmaceutical intermediate
(2S)-2-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]propan-1-ol
WBUHPAHBCMHESO-NZAAPPJWSA-N
C[C@H](CO)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C\3/C[C@H](C[C@@H](C3=C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C
—